Helogen builds fully automated factories in low‑Earth orbit to produce high‑value biomaterials that cannot be made on the ground. By exploiting microgravity, its robotic production lines achieve ultra‑pure crystal and protein synthesis, delivering specialty pharmaceuticals and advanced polymers with carbon‑positive scalability.
Funding
Funding not disclosed
Founders
Product
Problem
Current manufacturing of high‑value biomaterials is constrained by Earth's gravity, which limits achievable purity and prevents synthesis of certain medicines and advanced materials. This results in supply bottlenecks and reliance on energy‑intensive, carbon‑heavy processes that cannot meet emerging demand for ultra‑pure bioproducts.
Solution
Helogen constructs fully automated factories in low‑Earth orbit to produce biomaterials that are unattainable on the ground. By leveraging microgravity, the factories enable crystal growth and protein folding processes that yield unprecedented purity and structural integrity. The orbital facilities operate autonomously, using robotic production lines and closed‑loop resource recycling to achieve carbon‑positive scalability. Produced materials are returned to Earth via scheduled cargo missions, providing pharmaceutical and advanced‑material companies with a reliable source of high‑value bioproducts. This approach establishes the first step toward larger, modular orbital manufacturing complexes that can expand capacity without terrestrial constraints.
Target Audience
Primary customers are pharmaceutical manufacturers and advanced materials companies that require ultra‑pure biomolecules or specialty polymers unavailable from conventional Earth‑based production.
Features
- Fully automated, robotic production lines designed for microgravity environments
- Closed‑loop resource management to minimize waste and achieve carbon‑positive operation
- Precision crystal and protein synthesis processes that exploit the absence of sedimentation and convection
- Integrated payload handling for safe transport of finished biomaterials to Earth via cargo spacecraft
- Scalable modular factory architecture allowing incremental capacity expansion in orbit